Matrix Capital Management Company, LP
Insider CIK 1410830 · ADPT Director, 10% owner · AURA 10% owner · ZNTL 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| AURA Aura Biosciences, Inc. | S Sale | 2026-05-07 | 2026-05-11 | 6,922,870 | $5.64 | $39.04M | 0 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2025-12-15 | 2025-12-15 | 7,500,000 | $1.33 | $9.97M | 6,459,973 | SEC↗ |
| AURA Aura Biosciences, Inc. | P Buy | 2023-11-09 | 2023-11-09 | 1,560,000 | $9.00 | $14.04M | 6,922,870 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | P Buy | 2023-06-20 | 2023-06-20 | 4,760,000 | $22.66 | $107.86M | 13,959,973 | SEC↗ |
| AURA Aura Biosciences, Inc. | P Buy | 2022-12-05 | 2022-12-07 | 1,250,000 | $12.00 | $15.00M | 5,362,870 | SEC↗ |
| AURA Aura Biosciences, Inc. | C Conversion deriv | 2021-11-02 | 2021-11-04 | 2,327,870 | — | $0 | 0 | SEC↗ |
| AURA Aura Biosciences, Inc. | P Buy | 2021-11-02 | 2021-11-04 | 1,785,000 | $14.00 | $24.99M | 4,112,870 | SEC↗ |
| AURA Aura Biosciences, Inc. | C Conversion | 2021-11-02 | 2021-11-04 | 2,327,870 | — | $0 | 2,327,870 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2021-03-10 | 2021-03-10 | 25,732 | $41.47 | $1.07M | 12,339,358 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2021-03-10 | 2021-03-10 | 30,268 | $42.38 | $1.28M | 12,309,090 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2021-03-09 | 2021-03-10 | 34,302 | $41.16 | $1.41M | 12,365,090 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2021-03-09 | 2021-03-10 | 215,698 | $40.42 | $8.72M | 12,399,392 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2021-03-08 | 2021-03-10 | 85,911 | $41.62 | $3.58M | 12,615,090 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2021-03-08 | 2021-03-10 | 71,194 | $41.21 | $2.93M | 12,701,001 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2021-03-08 | 2021-03-10 | 33,600 | $39.97 | $1.34M | 12,772,195 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2021-03-08 | 2021-03-10 | 75,000 | $39.22 | $2.94M | 12,805,795 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2021-03-08 | 2021-03-10 | 234,295 | $38.22 | $8.95M | 12,880,795 | SEC↗ |
| ADPT Adaptive Biotechnologies C | S Sale | 2020-07-20 | 2020-07-22 | 2,000,000 | $40.00 | $80.00M | 13,115,090 | SEC↗ |
| ADPT Adaptive Biotechnologies C | C Conversion | 2020-01-24 | 2020-01-28 | 2,217,101 | $26.50 | $58.75M | 15,115,090 | SEC↗ |
| ADPT Adaptive Biotechnologies C | C Conversion deriv | 2019-07-01 | 2019-07-02 | 5,893,716 | — | $0 | 0 | SEC↗ |
| ADPT Adaptive Biotechnologies C | C Conversion deriv | 2019-07-01 | 2019-07-02 | 11,154,116 | — | $0 | 0 | SEC↗ |
| ADPT Adaptive Biotechnologies C | C Conversion deriv | 2019-07-01 | 2019-07-02 | 84,359 | — | $0 | 0 | SEC↗ |
| ADPT Adaptive Biotechnologies C | C Conversion deriv | 2019-07-01 | 2019-07-02 | 200,000 | — | $0 | 0 | SEC↗ |
| ADPT Adaptive Biotechnologies C | C Conversion | 2019-07-01 | 2019-07-02 | 5,893,716 | — | $0 | 6,093,716 | SEC↗ |
| ADPT Adaptive Biotechnologies C | C Conversion | 2019-07-01 | 2019-07-02 | 11,154,116 | — | $0 | 17,247,832 | SEC↗ |
| ADPT Adaptive Biotechnologies C | C Conversion | 2019-07-01 | 2019-07-02 | 84,359 | — | $0 | 17,332,191 | SEC↗ |
| ADPT Adaptive Biotechnologies C | C Conversion | 2019-07-01 | 2019-07-02 | 200,000 | — | $0 | 200,000 | SEC↗ |